株式会社グローバルインフォメーション
TEL: 044-952-0102
表紙
市場調査レポート

自己検査:医療機器のパイプライン評価

Self Testing - Medical Devices Pipeline Assessment, 2019

発行 GlobalData 商品コード 666930
出版日 ページ情報 英文 81 Pages
即納可能
価格
本日の銀行送金レート: 1USD=110.56円で換算しております。
Back to Top
自己検査:医療機器のパイプライン評価 Self Testing - Medical Devices Pipeline Assessment, 2019
出版日: 2019年11月01日 ページ情報: 英文 81 Pages
概要

当レポートでは、世界の自己検査の市場における、主要なパイプライン製品とその治験の進行状況について調査すると共に、製品の機能・特性の比較分析 (治験の進行段階別) や、主要企業・組織のプロファイルおよび代表的製品、昨今の市場動静 (業績報告・資本取引動向など) といった情報を取りまとめてお届けいたします。

第1章 目次

第2章 イントロダクション

  • 自己検査の概要

第3章 治験中の製品

  • パイプライン製品:治験段階別
  • パイプライン製品:地域別
  • パイプライン製品:規制経路別
  • パイプライン製品:推定認証時期別

第4章 自己検査:治験中のパイプライン製品、企業別

  • 自己検査の企業:治験段階別のパイプライン製品
  • 自己検査:治験段階別のパイプライン製品

第5章 自己検査市場:企業・製品の概要

  • Atomo Diagnostics Pty Limited
  • Boston Microfluidics
  • Entia Ltd
  • Morgan Innovation And Technology Ltd
  • Novosanis NV
  • OncoGenesis
  • Premier Medical Corporation
  • Shanghai Kehua Bio-engineering Co Ltd
  • Svenska Cellulosa Aktiebolaget
  • Wellmetrix LLC

第6章 自己検査市場:昨今の動向 (全37件)

第7章 付録

図表

List of Tables

  • Table 1: Self Testing - Pipeline Products by Stage of Development 7
  • Table 2: Self Testing - Pipeline Products by Territory 8
  • Table 3: Self Testing - Pipeline Products by Regulatory Path 9
  • Table 4: Self Testing - Pipeline Products by Estimat

List of Figures

  • Figure 1: Self Testing - Pipeline Products by Stage of Development 7
  • Figure 2: Self Testing - Pipeline Products by Territory 8
  • Figure 3: Self Testing - Pipeline Products by Regulatory Path 9
  • Figure 4: Self Testing - Pipeline Products by Es
目次
Product Code: GDME0796EPD

GlobalData's Medical Devices sector report, "Self Testing - Medical Devices Pipeline Assessment, 2019" provides an overview of Self Testing currently in pipeline stage.

The report provides comprehensive information on the pipeline products with comparative analysis of the products at various stages of development. The report reviews major players involved in the pipeline product development.

It also provides information about clinical trials in progress, which includes trial phase, trial status, trial start and end dates, and, the number of trials for the key Self Testing pipeline products.

This report is prepared using data sourced from in-house databases, secondary and primary research by GlobalData's team of industry experts.

Note: Certain sections in the report may be removed or altered based on the availability and relevance of data in relation to the equipment type.

Scope

  • Extensive coverage of the Self Testing under development
  • The report reviews details of major pipeline products which includes, product description, licensing and collaboration details and other developmental activities
  • The report reviews the major players involved in the development of Self Testing and list all their pipeline projects
  • The coverage of pipeline products based on various stages of development ranging from Early Development to Approved / Issued stage
  • The report provides key clinical trial data of ongoing trials specific to pipeline products
  • Recent developments in the segment / industry

Reasons to buy

The report enables you to -

  • Formulate significant competitor information, analysis, and insights to improve R&D strategies
  • Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage
  • Identify and understand important and diverse types of Self Testing under development
  • Develop market-entry and market expansion strategies
  • Plan mergers and acquisitions effectively by identifying major players with the most promising pipeline
  • In-depth analysis of the product's current stage of development, territory and estimated launch date

Table of Contents

1 Table of Contents

  • 1.1 List of Tables 4
  • 1.2 List of Figures 5

2 Introduction 6

  • 2.1 Self Testing Overview 6

3 Products under Development 7

  • 3.1 Self Testing - Pipeline Products by Stage of Development 7
  • 3.2 Self Testing - Pipeline Products by Territory 8
  • 3.3 Self Testing - Pipeline Products by Regulatory Path 9
  • 3.4 Self Testing - Pipeline Products by Estimated Approval Date 10
  • 3.5 Self Testing - Ongoing Clinical Trials 11

4 Self Testing - Pipeline Products under Development by Companies 12

  • 4.1 Self Testing Companies - Pipeline Products by Stage of Development 12
  • 4.2 Self Testing - Pipeline Products by Stage of Development 13

5 Self Testing Companies and Product Overview 14

  • 5.1 Atomo Diagnostics Pty Ltd Company Overview 14
    • 5.1.1 Atomo Diagnostics Pty Ltd Pipeline Products & Ongoing Clinical Trials Overview 14
  • 5.2 bioLytical Laboratories Inc Company Overview 18
    • 5.2.1 bioLytical Laboratories Inc Pipeline Products & Ongoing Clinical Trials Overview 18
  • 5.3 Boston Microfluidics Company Overview 20
    • 5.3.1 Boston Microfluidics Pipeline Products & Ongoing Clinical Trials Overview 20
  • 5.4 Brigham and Women's Hospital Company Overview 21
    • 5.4.1 Brigham and Women's Hospital Pipeline Products & Ongoing Clinical Trials Overview 21
  • 5.5 Emory University Company Overview 22
    • 5.5.1 Emory University Pipeline Products & Ongoing Clinical Trials Overview 22
  • 5.6 Entia Ltd Company Overview 23
    • 5.6.1 Entia Ltd Pipeline Products & Ongoing Clinical Trials Overview 23
  • 5.7 InnaMed Inc Company Overview 24
    • 5.7.1 InnaMed Inc Pipeline Products & Ongoing Clinical Trials Overview 24
  • 5.8 Morgan Innovation And Technology Ltd Company Overview 26
    • 5.8.1 Morgan Innovation And Technology Ltd Pipeline Products & Ongoing Clinical Trials Overview 26
  • 5.9 Novosanis NV Company Overview 27
    • 5.9.1 Novosanis NV Pipeline Products & Ongoing Clinical Trials Overview 27
  • 5.10 OncoGenesis Company Overview 28
    • 5.10.1 OncoGenesis Pipeline Products & Ongoing Clinical Trials Overview 28
  • 5.11 Premier Medical Corporation Company Overview 29
    • 5.11.1 Premier Medical Corporation Pipeline Products & Ongoing Clinical Trials Overview 29
  • 5.12 Shanghai Kehua Bio-engineering Co Ltd Company Overview 30
    • 5.12.1 Shanghai Kehua Bio-engineering Co Ltd Pipeline Products & Ongoing Clinical Trials Overview 30
  • 5.13 Svenska Cellulosa Aktiebolaget Company Overview 31
    • 5.13.1 Svenska Cellulosa Aktiebolaget Pipeline Products & Ongoing Clinical Trials Overview 31
  • 5.14 Tasso, Inc. Company Overview 32
    • 5.14.1 Tasso, Inc. Pipeline Products & Ongoing Clinical Trials Overview 32
  • 5.15 Wellmetrix LLC Company Overview 33
    • 5.15.1 Wellmetrix LLC Pipeline Products & Ongoing Clinical Trials Overview 33

6 Self Testing- Recent Developments 34

  • 6.1 Sep 10, 2019: EKF Diagnostics Holdings: Half-year Report 34
  • 6.2 Aug 19, 2019: Retirement of Dr. Sandra Horning & Appointment of Dr. Levi Garraway to Chief Medical Officer, Roche and Genentech 35
  • 6.3 Aug 12, 2019: Biocept reports second quarter 2019 financial results 35
  • 6.4 Jul 25, 2019: Roche reports very strong performance in the first half of 2019 - Outlook raised 37
  • 6.5 Jul 15, 2019: EKF Diagnostics Holdings: Trading update 41
  • 6.6 Jul 09, 2019: Mylan HIV Self Test receives WHO prequalification approval 42
  • 6.7 Jun 14, 2019: Klobuchar, Murkowski introduce Legislation to Protect Consumers' Private Health Data 42
  • 6.8 Jun 11, 2019: Changes in Roche's board of directors and corporate executive committee 44
  • 6.9 Jun 11, 2019: Regulators demand more details on Roche's $4.8bn Spark acquisition 45
  • 6.10 May 08, 2019: Biocept reports first quarter 2019 financial results 45
  • 6.11 Apr 25, 2019: Regarding the establishment of the new "EIKEN ROAD MAP 2019" management framework and the new medium-term management plan 47
  • 6.12 Apr 25, 2019: Eiken Chemical announced its financial results for the fiscal year ended March 31, 2019 49
  • 6.13 Apr 17, 2019: Roche reports a strong start in 2019 and raises the outlook for the full-year 49
  • 6.14 Apr 04, 2019: First HIV self-test approved for sale in Australia now available from Atomo Diagnostics 52
  • 6.15 Mar 28, 2019: Biocept reports 2018 fourth quarter and full year financial results 53
  • 6.16 Mar 21, 2019: Roche sues U.S. executives in fight over diabetes test strips 57
  • 6.17 Mar 13, 2019: EKF Diagnostics Holdings: Final results 57
  • 6.18 Feb 27, 2019: Biocept and Providence Saint John's Health Center collaborate to evaluate cerebrospinal fluid for use with liquid biopsy testing in metastatic cancer 62
  • 6.19 Jan 31, 2019: Roche reports very strong results in 2018 63
  • 6.20 Jan 24, 2019: Genentech announces Alexander Hardy as Chief Executive Officer 67
  • 6.21 Jan 11, 2019: Shimadzu's new preparative purification LC System provides high efficiency, saves space, and enables multi-sample processing 68
  • 6.22 Jan 07, 2019: MES to launch the first YO Home Sperm Test for PCs with personalized YO SCORE 69
  • 6.23 Jan 02, 2019: Roche Diabetes Care India appoints Dr. Gaurav Laroia as general manager 70
  • 6.24 Dec 13, 2018: Devicare announces the positive results of the clinical trial with Lit-Control to prevent the encrustation of catheters in patients with lithiasis 70
  • 6.25 Dec 11, 2018: Brigham researchers develop smartphone-based Ovulation Test 71
  • 6.26 Dec 10, 2018: New member proposed for election to Roche Board of Directors 72
  • 6.27 Dec 10, 2018: Roche names William Bill Anderson as CEO from January 01 2019 72
  • 6.28 Dec 03, 2018: Roche to increase its payroll in Switzerland by 1.2 percent 73
  • 6.29 Nov 30, 2018: European Patent granted for Colli-Pee 73
  • 6.30 Nov 29, 2018: Australian TGA approves Atomo HIV Self Test as first rapid diagnostic test for home use 73
  • 6.31 Nov 28, 2018: INSTI HIV Self Test earns WHO prequalification status for home testing 74
  • 6.32 Nov 08, 2018: Colli-Pee approved by Mexican Health Authority 75
  • 6.33 Oct 31, 2018: Biocept announces new executive hires to its sales and marketing organization 76
  • 6.34 Oct 25, 2018: Exeltis Spain launches the world's first ever digital urology solution 77

7 Appendix 78

  • 7.1 Methodology 78
  • 7.2 About GlobalData 81
  • 7.3 Contact Us 81
  • 7.4 Disclaimer 81
Back to Top